Equities

Standard Chem & Pharm Co Ltd

1720:TAI

Standard Chem & Pharm Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (TWD)63.30
  • Today's Change-0.300 / -0.47%
  • Shares traded315.84k
  • 1 Year change+5.32%
  • Beta--
Data delayed at least 20 minutes, as of Nov 14 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Standard Chem & Pharm Co Ltd is a Taiwan-based company principally engaged in the manufacture and sales of western pharmaceuticals, dietary supplement and active pharmaceutical ingredients. The Company’s products cover circulatory system drugs, digestive system drugs, respiratory system drugs, nervous system drugs, metabolic drugs and general foods and health foods. The Company is also engaged in the sales of medical equipment, animal medicine, cosmetics and milk powder. The Company's products are sold to domestic and overseas markets.

  • Revenue in TWD (TTM)6.71bn
  • Net income in TWD847.58m
  • Incorporated1967
  • Employees1.13k
  • Location
    Standard Chem & Pharm Co LtdNo.6-20Tuku, Tuku Village, Sinying DistrictTAINAN 730TaiwanTWN
  • Phone+886 66361516
  • Fax+886 66352817
  • Websitehttps://www.standard.com.tw/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Panion & BF Biotech Inc2.01bn101.27m7.95bn321.0078.524.2929.153.961.181.1823.4221.620.61851.739.66--3.124.084.825.6352.6652.375.045.930.869910.620.287111.06-21.545.96-57.65-13.4735.39-3.23
Adimmune Corp1.66bn-607.92m9.51bn564.00--1.86--5.74-1.44-1.443.9311.920.18481.254.04---8.270.6867-10.190.773927.8230.11-44.753.041.99-24.750.328432.80-20.7216.77-319.91--38.05--
Formosa Laboratories Inc4.69bn255.94m10.94bn480.0043.101.4618.232.332.112.1138.9062.490.34791.494.42--0.70672.680.96893.6144.3035.402.038.751.180.89220.315527.3815.8010.16-69.16-6.52-11.6032.22
Standard Chem & Pharm Co Ltd6.71bn847.58m11.37bn1.13k13.421.927.101.694.744.7437.5033.050.60662.396.00--10.989.6820.0217.6143.8143.7518.1017.021.93--0.079560.346.6411.802.3917.4029.9712.47
SCI Pharmtech Inc1.41bn484.24m11.47bn241.0024.052.1216.368.123.993.9913.9845.360.22111.824.61--7.586.908.568.2627.1138.1834.2619.851.689.220.169242.3833.83-9.10-4.55-8.0044.67-16.35
YungShin Global Holding Corp7.44bn1.05bn14.47bn1.57k13.741.9610.181.953.953.9527.9127.660.59531.475.51--9.106.6413.5810.2043.2845.1115.2910.451.35--0.103470.94-3.88-1.33-1.403.34-29.000.893
Data as of Nov 14 2024. Currency figures normalised to Standard Chem & Pharm Co Ltd's reporting currency: Taiwan Dollar TWD

Institutional shareholders

1.45%Per cent of shares held by top holders
HolderShares% Held
Dimensional Fund Advisors LPas of 03 Oct 20241.97m1.10%
Mellon Investments Corp.as of 03 Oct 2024218.00k0.12%
Dimensional Fund Advisors Ltd.as of 31 Aug 202499.19k0.06%
Arrowstreet Capital LPas of 30 Sep 202466.00k0.04%
Franklin Templeton SinoAm Securities Investment Mgmt, Incas of 04 Oct 202466.00k0.04%
SSgA Funds Management, Inc.as of 03 Oct 202461.00k0.03%
RAM Active Investments SAas of 30 Jun 202437.00k0.02%
DFA Australia Ltd.as of 30 Sep 202431.95k0.02%
American Century Investment Management, Inc.as of 03 Oct 202419.00k0.01%
LGT Capital Partners AG (Investment Management)as of 31 May 202413.00k0.01%
More ▼
Data from 30 Jun 2024 - 25 Oct 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.